ilaprazole has been researched along with Esophageal Reflux in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blandizzi, C; de Bortoli, N; Giacchino, M; Marchi, S; Martinucci, I; Savarino, E; Savarino, V | 1 |
Dulbecco, P; Martinucci, I; Ottonello, A; Savarino, E; Savarino, V | 1 |
Boileau, F; Cho, KD; Goldwater, R; Jung, WT; Kim, DY; Lee, SM; Park, DW; Periclou, AP | 1 |
2 review(s) available for ilaprazole and Esophageal Reflux
Article | Year |
---|---|
The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cytochrome P-450 CYP2C19; Drug Evaluation, Preclinical; Gastroesophageal Reflux; Half-Life; Humans; Omeprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic | 2013 |
Ilaprazole for the treatment of gastro-esophageal reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Gastroesophageal Reflux; Half-Life; Humans; Proton Pump Inhibitors | 2016 |
1 trial(s) available for ilaprazole and Esophageal Reflux
Article | Year |
---|---|
A comparative pharmacodynamic study of IY-81149 versus omeprazole in patients with gastroesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Analysis of Variance; Anti-Ulcer Agents; Area Under Curve; Benzimidazoles; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastric Acid; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Sulfoxides | 2000 |